Effect of age on chronic inflammation and responsiveness to bacterial and viral challenges

To identify reliable biomarkers of age-related changes in chronic inflammation and responsiveness to bacterial and viral challenges, we evaluated endogenous and ex vivo stimulated levels of 18 inflammatory markers, using whole blood collected in EDTA and sodium heparin tubes from 41 healthy volunteers, i.e., 11 men + 10 women aged 20–35 and 10 men + 10 women aged 50–77. These studies revealed significant differences in the levels of inflammatory markers when blood was collected in EDTA versus sodium heparin and age related differences in these biomarkers were confirmed with blood collected in EDTA from 120 healthy volunteers in 3 age categories, ie, 20 men + 20 women, aged 20–35, 36–49 and 50–77. Studies with unstimulated blood samples, to measure levels of chronic inflammation, revealed a significant increase with age in IL-12p70, CRP and PGE2, consistent with the concept of “inflammaging”, and a decrease in G-CSF in both men and women. Interestingly, in response to E. coli stimulation, PGE2 levels were markedly reduced in the 50–77 year old cohort while they were increased following Herpes Simplex virus-1 (HSV-1) stimulation, along with IL-8. In addition, unlike E. coli, HSV-1 potently stimulated IFNα production, but levels were dramatically reduced in the older cohort, consistent with a reduced ability to generate an anti-viral response. We also found platelets and CD8+ T cells were reduced with age while CD4+ T cells were significantly increased, resulting in a substantially higher CD4/CD8 ratio in the older cohort. Surprisingly, however, we found that the older cohort exhibited more T cell proliferation and IFNγ production in response to anti-CD3+anti-CD28 stimulation. Importantly, there was considerable person-to-person variation in these inflammatory markers in all age groups, making possible comparisons between a person’s “inflammage” and chronological age. These assays should help to identify individuals at high risk of autoimmune disorders and cancer.

[1]  G. Castellani,et al.  Inflammaging and human longevity in the omics era , 2017, Mechanisms of Ageing and Development.

[2]  D. Ganea,et al.  Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf , 2017, PloS one.

[3]  J. Hamilton,et al.  G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease , 2017, The Journal of Immunology.

[4]  C. Franceschi,et al.  Inflammaging and ‘Garb-aging’ , 2017, Trends in Endocrinology & Metabolism.

[5]  C. Auffray,et al.  Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells , 2017, The Journal of Immunology.

[6]  M. Manz,et al.  Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment , 2016, Front. Immunol..

[7]  G. Sergi,et al.  Inflammation and frailty in the elderly: A systematic review and meta-analysis , 2016, Ageing Research Reviews.

[8]  B. S. Sørensen,et al.  An evaluation of multiplex bead-based analysis of cytokines and soluble proteins in archived lithium heparin plasma, EDTA plasma and serum samples , 2016, Scandinavian journal of clinical and laboratory investigation.

[9]  Martin Jaeger,et al.  Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi , 2016, Nature Medicine.

[10]  S. Gangemi,et al.  Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity , 2015, Archivum Immunologiae et Therapiae Experimentalis.

[11]  B. Blomberg,et al.  Inflammaging decreases adaptive and innate immune responses in mice and humans , 2015, Biogerontology.

[12]  Daohong Zhou,et al.  Granulocyte colony-stimulating factor exacerbates hematopoietic stem cell injury after irradiation , 2015, Cell & Bioscience.

[13]  A. Pera,et al.  Immunosenescence: Implications for response to infection and vaccination in older people. , 2015, Maturitas.

[14]  F. Bolgert,et al.  Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation , 2014, Cellular and Molecular Immunology.

[15]  C. Franceschi,et al.  Inflammaging and Cancer: A Challenge for the Mediterranean Diet , 2015, Nutrients.

[16]  B. Seliger,et al.  Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity , 2014, Clinical Cancer Research.

[17]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  M. Feldman,et al.  Is CRP, like ESR, Age and Gender Dependent? , 2014 .

[19]  D. Link,et al.  G-CSF regulates hematopoietic stem cell activity, in part, through activation of toll-like receptor signaling , 2014, Leukemia.

[20]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[21]  Ruth R. Montgomery,et al.  Age-dependent dysregulation of innate immunity , 2013, Nature Reviews Immunology.

[22]  C. Coch,et al.  A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA , 2013, PloS one.

[23]  M. Hacker,et al.  A whole blood assay as a simple, broad assessment of cytokines and chemokines to evaluate human immune responses to Mycobacterium tuberculosis antigens. , 2013, Acta tropica.

[24]  J. P. McCoy,et al.  Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. , 2012, Cytokine.

[25]  E. Pamer,et al.  Antibiotics, microbiota, and immune defense. , 2012, Trends in immunology.

[26]  S. Bauer,et al.  Toll-like receptor 9, what o'clock is it? , 2012, Immunity.

[27]  T. Wurdinger,et al.  Cutting Edge: A Variant of the IL-23R Gene Associated with Inflammatory Bowel Disease Induces Loss of MicroRNA Regulation and Enhanced Protein Production , 2012, The Journal of Immunology.

[28]  G. Sethi,et al.  Multifaceted link between cancer and inflammation. , 2012, Bioscience reports.

[29]  J. Arnal,et al.  The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling. , 2012, Blood.

[30]  M. López-Hoyos,et al.  Aging is associated with circulating cytokine dysregulation. , 2012, Cellular immunology.

[31]  K. Clément,et al.  Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.

[32]  S. Howie.  Go girls! Efficient female innate immunity. , 2011, Blood.

[33]  M. Karin,et al.  Tumor promotion via injury- and death-induced inflammation. , 2011, Immunity.

[34]  D. Lowe,et al.  Chronic inflammation and immunologic-based constraints in malignant disease. , 2011, Immunotherapy.

[35]  B. Nordestgaard,et al.  Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer , 2011, Critical reviews in clinical laboratory sciences.

[36]  Sungha Park,et al.  Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays , 2011, Journal of Translational Medicine.

[37]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[38]  F. Murgia,et al.  Analysis of 12,517 inhabitants of a Sardinian geographic isolate reveals that predispositions to thrombocytopenia and thrombocytosis are inherited traits , 2011, Haematologica.

[39]  C. Rooney,et al.  Enhancement of dendritic cells as vaccines for cancer. , 2010, Immunotherapy.

[40]  S. Patterson,et al.  Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. , 2010, Clinical chemistry.

[41]  J. G. van der Hoeven,et al.  Lipopolysaccharide-stimulated whole blood cytokine production does not predict the inflammatory response in human endotoxemia , 2010, Innate immunity.

[42]  Pamela A McCombe,et al.  The effect of ageing on human lymphocyte subsets: comparison of males and females , 2010, Immunity & Ageing.

[43]  K. Mossman,et al.  Innate and Adaptive Immune Responses to Herpes Simplex Virus , 2009, Viruses.

[44]  R. Effros,et al.  Immunosenescence: what does it mean to health outcomes in older adults? , 2009, Current opinion in immunology.

[45]  B. Aggarwal,et al.  Inflammation and cancer: how friendly is the relationship for cancer patients? , 2009, Current opinion in pharmacology.

[46]  B. Jasani,et al.  Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. , 2009, Vaccine.

[47]  A. Sandler,et al.  CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. , 2009, Advanced drug delivery reviews.

[48]  Ashok Kumar,et al.  The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. , 2009, Inflammation & allergy drug targets.

[49]  G. Sen,et al.  Interferons and viral infections , 2009, BioFactors.

[50]  Jun Tan,et al.  Inflammaging as a prodrome to Alzheimer's disease , 2008, Journal of Neuroinflammation.

[51]  M. Rieder,et al.  Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. , 2008, American journal of respiratory and critical care medicine.

[52]  Anis Larbi,et al.  Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people , 2008, Immunity & Ageing.

[53]  P. Anderson.  Post-transcriptional control of cytokine production , 2008, Nature Immunology.

[54]  B. White,et al.  Concentration-dependent roles for heparin in modifying liopolysaccharide-induced activation of mononuclear cells in whole blood , 2008, Thrombosis and Haemostasis.

[55]  C. Franceschi,et al.  The immune system in extreme longevity , 2008, Experimental Gerontology.

[56]  Michael Müller,et al.  Fasting induces changes in peripheral blood mononuclear cell gene expression profiles related to increases in fatty acid beta-oxidation: functional role of peroxisome proliferator activated receptor alpha in human peripheral blood mononuclear cells. , 2007, The American journal of clinical nutrition.

[57]  K. Tracey,et al.  Aerobic exercise attenuates inducible TNF production in humans. , 2007, Journal of applied physiology.

[58]  J. Andersen,et al.  Prostaglandin E2 Is a Major Inhibitor of Dendritic Cell Maturation and Function in Ixodes scapularis Saliva1 , 2007, The Journal of Immunology.

[59]  M. Bayer,et al.  Heparin and EDTA as anticoagulant differentially affect cytokine mRNA level of cultured porcine blood cells. , 2007, Journal of immunological methods.

[60]  L. Herzenberg,et al.  Importance of culturing primary lymphocytes at physiological oxygen levels , 2007, Proceedings of the National Academy of Sciences.

[61]  P. Alard,et al.  Reversing Tumor Immune Suppression with Intratumoral IL-12: Activation of Tumor-Associated T Effector/Memory Cells, Induction of T Suppressor Apoptosis, and Infiltration of CD8+ T Effectors1 , 2006, The Journal of Immunology.

[62]  Roger E Bumgarner,et al.  Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity 1 , 2005, The Journal of Immunology.

[63]  P. Moss,et al.  The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age , 2005, Clinical and experimental immunology.

[64]  S. Bandinelli,et al.  The origins of age-related proinflammatory state. , 2005, Blood.

[65]  M. Heinzelmann,et al.  Heparin Binds to Lipopolysaccharide (LPS)-Binding Protein, Facilitates the Transfer of LPS to CD14, and Enhances LPS-Induced Activation of Peripheral Blood Monocytes1 , 2005, The Journal of Immunology.

[66]  H. Schreiber,et al.  Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.

[67]  Dayong Wu,et al.  Mechanism of age-associated up-regulation in macrophage PGE2 synthesis , 2004, Brain, Behavior, and Immunity.

[68]  M. Febbraio,et al.  The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? , 2004, The Proceedings of the Nutrition Society.

[69]  F. Deinhardt,et al.  Age-related decline of human interferon alpha and interferon gamma production , 1984, Blut: Zeitschrift für die Gesamte Blutforschung.

[70]  E. Gardner,et al.  Age-related changes in Type 1 and Type 2 cytokine production in humans , 2004, Biogerontology.

[71]  Hideo Negishi,et al.  Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence , 2003, Nature.

[72]  K. Honda,et al.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. , 2003, Nature.

[73]  F. Siegal,et al.  Circulating, Interferon‐Producing Plasmacytoid Dendritic Cells Decline During Human Ageing , 2002, Scandinavian journal of immunology.

[74]  D. Tough,et al.  Links between innate and adaptive immunity via type I interferon. , 2002, Current opinion in immunology.

[75]  M. Carrington,et al.  correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer , 2001, Nature.

[76]  M. Passeri,et al.  Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes , 2001, Experimental Gerontology.

[77]  S. Meydani,et al.  Interleukin-6 production does not increase with age. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[78]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[79]  Age-Associated Changes in Interferon-γ and Interleukin-4 Secretion by Purified Human CD4+ and CD8+ T Cells , 2000 .

[80]  J. Steffen.  The role of interleukin-1 polymorphism in the pathogenesis of gastric cancer , 2000 .

[81]  E. Keller,et al.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. , 2000, Annual review of medicine.

[82]  P. Calder,et al.  Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. , 1999, Cytokine.

[83]  M. Gordon,et al.  IL-12 is a heparin-binding cytokine. , 1999, Journal of immunology.

[84]  D. Murasko,et al.  Effect of age on cytokine production in humans , 1998, AGE.

[85]  Dayong Wu,et al.  Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. , 1998, American journal of physiology. Cell physiology.

[86]  C. Franceschi,et al.  T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians , 1997, Mechanisms of Ageing and Development.

[87]  C. Franceschi,et al.  Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians , 1996, Immunology.

[88]  J. Born,et al.  Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep , 1995, Mechanisms of Ageing and Development.

[89]  T. C. Peterson,et al.  Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopolysaccharide , 1994, Mechanisms of Ageing and Development.

[90]  Richard A. Miller,et al.  Age-associated changes in human T cell phenotype and function , 1994, Aging.

[91]  J. Riancho,et al.  Age-related differences in cytokine secretion. , 1994, Gerontology.

[92]  F. Welt,et al.  Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex , 1989, The Journal of cell biology.

[93]  H. Saba,et al.  Effect of heparin on platelet aggregation , 1984, American journal of hematology.

[94]  R. Messner,et al.  Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. , 1979, The Journal of clinical investigation.